Literature DB >> 18692615

SILCS diaphragm: postcoital testing of a new single-size contraceptive device.

Jill L Schwartz1, Susan A Ballagh, Mitchell D Creinin, Robert W Rountree, Maggie Kilbourne-Brook, Christine K Mauck, Marianne M Callahan.   

Abstract

BACKGROUND: This study was conducted to compare the effectiveness of a new, single-size silicone contraceptive diaphragm used with either spermicide [2% nonoxynol-9 (N-9)] or lubricant in preventing sperm from penetrating midcycle cervical mucus. STUDY
DESIGN: A crossover postcoital test (PCT) in healthy, sexually active women not at risk for pregnancy due to tubal occlusion was conducted. Couples had a baseline PCT without a device to verify normal fertility parameters. Qualified couples underwent up to two test cycles using the SILCS diaphragm with a metal spring. A subgroup of couples underwent a third test cycle with the SILCS polymer spring diaphragm used with N-9 gel.
RESULTS: Fifteen couples completed a baseline cycle and were randomized to order of study gel. Of these, 14 couples completed a baseline cycle and at least one test cycle, 12 couples completed a baseline cycle and two test cycles and 8 couples completed a third test cycle with the polymer spring prototype. Sperm was detected in the vaginal pool in all completed test cycles. The SILCS metal spring diaphragms used with N-9 gel reduced the average number of progressively motile sperm per high power field in the cervical mucus from a baseline of 12.5 to 0, while use of this device with lubricant reduced the number to 0.5. The SILCS polymer spring diaphragm used with N-9 performed the same as the metal spring used with N-9.
CONCLUSION: The SILCS diaphragm used with N-9 gel performed well. It is likely that the SILCS diaphragm will give acceptable results in a contraceptive effectiveness study but that adjunctive use of a chemical barrier such as N-9 gel will be necessary for it to be most effective.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692615     DOI: 10.1016/j.contraception.2008.04.118

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

Review 1.  Contraception technology: past, present and future.

Authors:  Regine Sitruk-Ware; Anita Nath; Daniel R Mishell
Journal:  Contraception       Date:  2012-09-17       Impact factor: 3.375

2.  An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.

Authors:  Sara Pentlicky; Mark Rosen; Patricia S Coffey; M Kilbourne-Brook; A Shaunik; Courtney A Schreiber; Kurt Barnhart
Journal:  Contraception       Date:  2012-08-13       Impact factor: 3.375

3.  Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay.

Authors:  Margaret C Snead; Johan H Melendez; Athena P Kourtis; Dorothy M Chaney; Teresa M Brown; Carolyn M Black; Christine K Mauck; Jill L Schwartz; Jonathan M Zenilman; Denise J Jamieson; Maurizio Macaluso; Gustavo F Doncel
Journal:  Contraception       Date:  2013-11-12       Impact factor: 3.375

4.  Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards.

Authors:  Margaret C Snead; Athena P Kourtis; Carolyn M Black; Christine K Mauck; Teresa M Brown; Ana Penman-Aguilar; Johan H Melendez; Maria F Gallo; Denise J Jamieson; Maurizio Macaluso
Journal:  Contraception       Date:  2012-12-04       Impact factor: 3.375

Review 5.  Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Gustavo F Doncel
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-09

6.  How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa.

Authors:  Fern Terris-Prestholt; Kara Hanson; Catherine MacPhail; Peter Vickerman; Helen Rees; Charlotte Watts
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

7.  Drug-eluting fibers for HIV-1 inhibition and contraception.

Authors:  Cameron Ball; Emily Krogstad; Thanyanan Chaowanachan; Kim A Woodrow
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

8.  Vaginal rings for delivery of HIV microbicides.

Authors:  R Karl Malcolm; Susan M Fetherston; Clare F McCoy; Peter Boyd; Ian Major
Journal:  Int J Womens Health       Date:  2012-11-20

9.  Cost-Effectiveness of Introducing the SILCS Diaphragm in South Africa.

Authors:  Aurélia Lépine; Neeti Nundy; Maggie Kilbourne-Brook; Mariana Siapka; Fern Terris-Prestholt
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 10.  Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†.

Authors:  Deborah J Anderson; Joseph A Politch; Richard A Cone; Larry Zeitlin; Samuel K Lai; Philip J Santangelo; Thomas R Moench; Kevin J Whaley
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.